Publication date
August 2020
DOIAbstract
Supplementary figure for the publication by Yu DA et al. Oral Janus kinase inhibitors for the treatment of alopecia areata: a systematic review and meta-analysis. J Am Acad Dermatol 2019
Supplementary figure for the publication by Yu DA et al. Oral Janus kinase inhibitors for the treatment of alopecia areata: a systematic review and meta-analysis. J Am Acad Dermatol 2019
Alopecia areata (AA) is a common auto-immune condition which results in chronic and recurrent non-sc...
Alopecia areata (AA) is a multifactorial immune-mediated condition, accompanied by damage to the hai...
Alopecia areata (AA) is a genetic, immune-mediated disease targeting hair follicles resulting in pat...
Supplementary data for the publication by Yu DA et al. Oral Janus kinase inhibitors for the treatmen...
Supplementary table for the publication by Yu DA et al. Oral Janus kinase inhibitors for the treatme...
Supplemental material, Figure S1, for The Use of Janus Kinase Inhibitors for Lichen Planus: An Evide...
Copyright © 2019 John Wiley & Sons, Inc. All rights reserved.Alopecia areata (AA) is a non-scarring ...
Background: Alopecia areata (AA) is a common autoimmune disorder characterized by patchy hair loss. ...
Supplemental material for manuscript published in the Journal for the American Academy of Dermatolog...
Kerry-Ann L Dillon 1, 2 1Department of Microbiology, Immunology and Pharmacology, St. George’...
Supplemental material, Online supplementary file 2, for The Use of Janus Kinase Inhibitors for Liche...
Supplemental material, Online supplementary file 1, for The Use of Janus Kinase Inhibitors for Liche...
Korn Triyangkulsri, Poonkiat Suchonwanit Division of Dermatology, Department of Medicine, Faculty o...
Supplemental material, Online supplementary file 3, for The Use of Janus Kinase Inhibitors for Liche...
Supplemental material, Figure S1, for Management of Hidradenitis Suppurativa Using Janus Kinase Inhi...
Alopecia areata (AA) is a common auto-immune condition which results in chronic and recurrent non-sc...
Alopecia areata (AA) is a multifactorial immune-mediated condition, accompanied by damage to the hai...
Alopecia areata (AA) is a genetic, immune-mediated disease targeting hair follicles resulting in pat...
Supplementary data for the publication by Yu DA et al. Oral Janus kinase inhibitors for the treatmen...
Supplementary table for the publication by Yu DA et al. Oral Janus kinase inhibitors for the treatme...
Supplemental material, Figure S1, for The Use of Janus Kinase Inhibitors for Lichen Planus: An Evide...
Copyright © 2019 John Wiley & Sons, Inc. All rights reserved.Alopecia areata (AA) is a non-scarring ...
Background: Alopecia areata (AA) is a common autoimmune disorder characterized by patchy hair loss. ...
Supplemental material for manuscript published in the Journal for the American Academy of Dermatolog...
Kerry-Ann L Dillon 1, 2 1Department of Microbiology, Immunology and Pharmacology, St. George’...
Supplemental material, Online supplementary file 2, for The Use of Janus Kinase Inhibitors for Liche...
Supplemental material, Online supplementary file 1, for The Use of Janus Kinase Inhibitors for Liche...
Korn Triyangkulsri, Poonkiat Suchonwanit Division of Dermatology, Department of Medicine, Faculty o...
Supplemental material, Online supplementary file 3, for The Use of Janus Kinase Inhibitors for Liche...
Supplemental material, Figure S1, for Management of Hidradenitis Suppurativa Using Janus Kinase Inhi...
Alopecia areata (AA) is a common auto-immune condition which results in chronic and recurrent non-sc...
Alopecia areata (AA) is a multifactorial immune-mediated condition, accompanied by damage to the hai...
Alopecia areata (AA) is a genetic, immune-mediated disease targeting hair follicles resulting in pat...
Add to ORKG